{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:16:14Z","timestamp":1794338174923,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Patients with severe tricuspid regurgitation (TR) are at risk for significant morbidity and mortality. Transcatheter tricuspid valve interventions (TTVI) may offer patients less invasive treatment alternatives to surgery. This review evaluates the most common class of device currently used worldwide to treat TR, tricuspid transcatheter edge-to-edge repair (T-TEER) and\u00a0orthotopic transcatheter tricuspid valve replacement (TTVR), both of which are now approved in the USA and Europe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>The first pivotal randomized clinical trial, TRILUMINATE, demonstrated that T-TEER can safely reduce TR and is associated with improved health status outcomes. However, results of this trial have raised questions about whether this device can provide sufficient TR reduction to impact clinical outcomes. Orthotopic TTVR has recently gained attention with initial data suggesting near-complete TR elimination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>The current review examines the technical features and anatomic limitations of the most commonly used devices for T-TEER and orthotopic TTVR, discusses the current clinical data for these devices, and offers a theoretical construct for device selection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-024-02051-4","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T10:01:53Z","timestamp":1718618513000},"page":"459-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Transcatheter Therapy for the Tricuspid Valve: A Focused Review of Edge-to-Edge Repair and Orthotopic Valve Replacement"],"prefix":"10.1007","volume":"26","author":[{"given":"Mahesh V.","family":"Madhavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratika","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca T.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"2051_CR1","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"\u2022 Hahn RT. Tricuspid regurgitation. N Engl J Med. 2023;388:1876\u201391.\u00a0This comprehensive review summarizes the anatomy, pathophysiology, epidemiology, and available clinical data for tricuspid valve disease.","journal-title":"N Engl J Med"},{"key":"2051_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.echo.2022.04.003","volume":"35","author":"S Offen","year":"2022","unstructured":"Offen S, Playford D, Strange G, Stewart S, Celermajer DS. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia. J Am Soc Echocardiogr. 2022;35:810\u20137.","journal-title":"J Am Soc Echocardiogr"},{"key":"2051_CR4","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","volume":"74","author":"M Taramasso","year":"2019","unstructured":"Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:2998\u20133008.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR5","first-page":"1","volume":"12","author":"RJ Henning","year":"2022","unstructured":"Henning RJ. Tricuspid valve regurgitation: current diagnosis and treatment. Am J Cardiovasc Dis. 2022;12:1\u201318.","journal-title":"Am J Cardiovasc Dis"},{"key":"2051_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","volume":"77","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77:450\u2013500.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561\u2013632.","journal-title":"Eur Heart J"},{"key":"2051_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.athoracsur.2022.12.041","volume":"115","author":"Q Chen","year":"2023","unstructured":"Chen Q, Bowdish ME, Malas J, Roach A, Gill G, Rowe G, et al. Isolated tricuspid operations: the society of thoracic surgeons adult cardiac surgery database analysis. Ann Thorac Surg. 2023;115:1162\u201370.","journal-title":"Ann Thorac Surg"},{"key":"2051_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4244\/EIJ-D-22-00442","volume":"18","author":"A Scotti","year":"2022","unstructured":"Scotti A, Sturla M, Granada JF, Kodali SK, Coisne A, Mangieri A, et al. Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies. EuroIntervention. 2022;18:840\u201351.","journal-title":"EuroIntervention"},{"key":"2051_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jchf.2023.07.020","volume":"11","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Brener MI, Cox ZL, Pinney S, Lindenfeld J. Tricuspid regurgitation management for heart\u00a0failure. JACC Heart Fail. 2023;11:1084\u2013102.","journal-title":"JACC Heart Fail"},{"key":"2051_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/eurheartj\/ehy641","volume":"40","author":"N Wang","year":"2019","unstructured":"Wang N, Fulcher J, Abeysuriya N, McGrady M, Wilcox I, Celermajer D, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019;40:476\u201384.","journal-title":"Eur Heart J"},{"key":"2051_CR12","doi-asserted-by":"crossref","unstructured":"Hahn RT, Badano LP, Bartko PE, Muraru D, Maisano F, Zamorano JL, et al. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. Eur Heart J Cardiovas Imaging. 2022.","DOI":"10.1093\/ehjci\/jeac009"},{"key":"2051_CR13","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.jacc.2023.03.392","volume":"81","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Lerakis S, Delgado V, Addetia K, Burkhoff D, Muraru D, et al. Multimodality imaging of right heart function: JACC scientific statement. J Am Coll Cardiol. 2023;81:1954\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.hfc.2023.03.008","volume":"19","author":"V Agarwal","year":"2023","unstructured":"Agarwal V, Hahn R. Tricuspid regurgitation and right heart failure: the role of imaging in defining pathophysiology, presentation, and novel management strategies. Heart Fail Clin. 2023;19:505\u201323.","journal-title":"Heart Fail Clin"},{"key":"2051_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ejcts.2011.01.017","volume":"39","author":"O Alfieri","year":"2011","unstructured":"Alfieri O, Denti P. Alfieri stitch and its impact on mitral clip. Eur J Cardiothorac Surg. 2011;39:807\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2051_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2021.07.006","volume":"35","author":"RT Hahn","year":"2022","unstructured":"Hahn RT, Saric M, Faletra FF, Garg R, Gillam LD, Horton K, et al. Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of Echocardiography. J Am Soc Echocardiogr. 2022;35:1\u201376.","journal-title":"J Am Soc Echocardiogr"},{"key":"2051_CR17","doi-asserted-by":"publisher","first-page":"e011118","DOI":"10.1161\/CIRCINTERVENTIONS.121.011118","volume":"14","author":"MF Eleid","year":"2021","unstructured":"Eleid MF, Alkhouli M, Thaden JJ, Zahr F, Chadderdon S, Guerrero M, et al. Utility of intracardiac echocardiography in the early experience of transcatheter edge to edge tricuspid valve repair. Circ Cardiovasc Interv. 2021;14:e011118.","journal-title":"Circ Cardiovasc Interv"},{"key":"2051_CR18","doi-asserted-by":"crossref","first-page":"e012888","DOI":"10.1161\/CIRCINTERVENTIONS.122.012888","volume":"16","author":"RS von Bardeleben","year":"2023","unstructured":"von Bardeleben RS, Lurz P, Sorajja P, Ruf T, Hausleiter J, Sitges M, et al. Two-year outcomes for tricuspid repair with a transcatheter edge-to-edge valve repair from the transatlantic TRILUMINATE trial. Circ Cardiovasc Interv. 2023;16:e012888.","journal-title":"Circ Cardiovasc Interv"},{"key":"2051_CR19","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023;388:1833\u201342. This study marks the first pivotal randomized clinical trial evaluating the use of triscuspid transcatheter edge-to-edge repair in patients with tricuspid regurgitation.","DOI":"10.1056\/NEJMoa2300525"},{"key":"2051_CR20","doi-asserted-by":"crossref","unstructured":"Maznyczka A, Pilgrim T. Antithrombotic treatment after transcatheter valve interventions: current status and future directions. Clin Ther. 2023.","DOI":"10.1016\/j.clinthera.2023.09.028"},{"key":"2051_CR21","first-page":"87","volume":"11","author":"AB Greenbaum","year":"2022","unstructured":"Greenbaum AB, Babaliaros VC, Eng MH. Orthotopic transcatheter tricuspid valve replacement. Interv Cardiol Clin. 2022;11:87\u201394.","journal-title":"Interv Cardiol Clin"},{"key":"2051_CR22","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.jcin.2020.06.040","volume":"13","author":"J Webb","year":"2020","unstructured":"Webb J, Hensey M, Fam N, Rod\u00e9s-Cabau J, Daniels D, Smith R, et al. Transcatheter mitral valve replacement with the transseptal EVOQUE system. JACC Cardiovasc Interv. 2020;13:2418\u201326.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcin.2020.11.045","volume":"14","author":"NP Fam","year":"2021","unstructured":"Fam NP, von Bardeleben RS, Hensey M, Kodali SK, Smith RL, Hausleiter J, et al. Transfemoral transcatheter tricuspid valve replacement with the EVOQUE system: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2021;14:501\u201311.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcin.2022.01.280","volume":"15","author":"JG Webb","year":"2022","unstructured":"Webb JG, Chuang AM, Meier D, von Bardeleben RS, Kodali SK, Smith RL, et al. Transcatheter tricuspid valve replacement with the EVOQUE system: 1-year outcomes of a multicenter, first-in-human experience. JACC Cardiovasc Interv. 2022;15:481\u201391.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcin.2022.01.016","volume":"15","author":"S Kodali","year":"2022","unstructured":"Kodali S, Hahn RT, George I, Davidson CJ, Narang A, Zahr F, et al. Transfemoral tricuspid valve replacement in patients with tricuspid regurgitation: TRISCEND study 30-day results. JACC Cardiovasc Interv. 2022;15:471\u201380.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR26","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1093\/eurheartj\/ehad667","volume":"44","author":"S Kodali","year":"2023","unstructured":"Kodali S, Hahn RT, Makkar R, Makar M, Davidson CJ, Puthumana JJ, et al. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur Heart J. 2023;44:4862\u201373.","journal-title":"Eur Heart J"},{"key":"2051_CR27","doi-asserted-by":"publisher","first-page":"1171968","DOI":"10.3389\/fcvm.2023.1171968","volume":"10","author":"S Tomlinson","year":"2023","unstructured":"Tomlinson S, Rivas CG, Agarwal V, Lebehn M, Hahn RT. Multimodality imaging for transcatheter tricuspid valve repair and replacement. Front Cardiovasc Med. 2023;10:1171968.","journal-title":"Front Cardiovasc Med"},{"key":"2051_CR28","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jacc.2023.08.008","volume":"82","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, et al. Tricuspid valve academic research consortium definitions for tricuspid regurgitation and trial endpoints. J Am Coll Cardiol. 2023;82:1711\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR29","doi-asserted-by":"publisher","first-page":"891468","DOI":"10.3389\/fcvm.2022.891468","volume":"9","author":"V Dannenberg","year":"2022","unstructured":"Dannenberg V, Koschutnik M, Don\u00e0 C, Nitsche C, Mascherbauer K, Heitzinger G, et al. Invasive hemodynamic assessment and procedural success of transcatheter tricuspid valve repair-important factors for right ventricular remodeling and outcome. Front Cardiovasc Med. 2022;9:891468.","journal-title":"Front Cardiovasc Med"},{"key":"2051_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2023.05.008","volume":"82","author":"P Lurz","year":"2023","unstructured":"Lurz P, Besler C, Schmitz T, Bekeredjian R, Nickenig G, Mollmann H, et al. Short-term outcomes of tricuspid edge-to-edge repair in clinical practice. J Am Coll Cardiol. 2023;82:281\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR31","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jcin.2022.05.041","volume":"15","author":"MG Wild","year":"2022","unstructured":"Wild MG, L\u00f6w K, Rosch S, Ger\u00e7ek M, Higuchi S, Massberg S, et al. Multicenter experience with the transcatheter leaflet repair system for symptomatic tricuspid regurgitation. JACC Cardiovasc Interv. 2022;15:1352\u201363.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR32","doi-asserted-by":"crossref","unstructured":"Hahn RT, Weckbach LT, Noack T, Hamid N, Kitamura M, Bae R, et al. Proposal for a standard echocardiographic tricuspid valve nomenclature. JACC Cardiovasc Imaging. 2021.","DOI":"10.1016\/j.jcmg.2021.01.012"},{"key":"2051_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4244\/EIJ-D-21-00695","volume":"17","author":"F Praz","year":"2021","unstructured":"Praz F, Muraru D, Kreidel F, Lurz P, Hahn RT, Delgado V, et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021;17:791\u2013808.","journal-title":"EuroIntervention"},{"key":"2051_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jcin.2018.05.002","volume":"11","author":"C Besler","year":"2018","unstructured":"Besler C, Orban M, Rommel KP, Braun D, Patel M, Hagl C, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2018;11:1119\u201328.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR35","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jcin.2021.03.033","volume":"14","author":"TF Ruf","year":"2021","unstructured":"Ruf TF, Hahn RT, Kreidel F, Beiras-Fernandez A, Hell M, Gerdes P, et al. Short-term clinical outcomes of transcatheter tricuspid valve repair with the third-generation MitraClip XTR system. JACC Cardiovasc Interv. 2021;14:1231\u201340.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR36","doi-asserted-by":"crossref","unstructured":"Tanaka T, Sugiura A, Kavsur R, Vogelhuber J, \u00d6zt\u00fcrk C, Becher MU, et al. Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair. EuroIntervention. 2022.","DOI":"10.1093\/eurheartj\/ehab724.2224"},{"key":"2051_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jcin.2019.10.058","volume":"13","author":"M Taramasso","year":"2020","unstructured":"Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A, et al. Outcomes of TTVI in patients with pacemaker or defibrillator leads: data from the TriValve registry. JACC Cardiovasc Interv. 2020;13:554\u201364.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.jcin.2019.05.034","volume":"12","author":"J Lurz","year":"2019","unstructured":"Lurz J, Rommel KP, Unterhuber M, Besler C, Noack T, Borger M, et al. Safety and efficacy of transcatheter edge-to-edge repair of the tricuspid valve in patients with cardiac implantable electronic device leads. JACC Cardiovasc Interv. 2019;12:2114\u20136.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR39","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.jcin.2021.03.052","volume":"14","author":"M Kitamura","year":"2021","unstructured":"Kitamura M, Kresoja KP, Besler C, Leontyev S, Kiefer P, Rommel KP, et al. Impact of tricuspid valve morphology on clinical outcomes after transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2021;14:1616\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR40","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jcin.2021.07.048","volume":"14","author":"A Sugiura","year":"2021","unstructured":"Sugiura A, Tanaka T, Kavsur R, \u00d6zt\u00fcrk C, Vogelhuber J, Wilde N. Leaflet configuration and residual tricuspid regurgitation after transcatheter edge-to-edge tricuspid repair. JACC Cardiovasc Interv. 2021;14:2260\u201370.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR41","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1161\/CIRCULATIONAHA.109.924613","volume":"121","author":"JG Webb","year":"2010","unstructured":"Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rod\u00e9s-Cabau J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848\u201357.","journal-title":"Circulation"},{"key":"2051_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.acvd.2014.07.051","volume":"107","author":"F Godart","year":"2014","unstructured":"Godart F, Baruteau AE, Petit J, Riou JY, Sassolas F, Lusson JR, et al. Transcatheter tricuspid valve implantation: a multicentre French study. Arch Cardiovasc Dis. 2014;107:583\u201391.","journal-title":"Arch Cardiovasc Dis"},{"key":"2051_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jacc.2018.10.051","volume":"73","author":"DB McElhinney","year":"2019","unstructured":"McElhinney DB, Aboulhosn JA, Dvir D, Whisenant B, Zhang Y, Eicken A, et al. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019;73:148\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR44","doi-asserted-by":"crossref","unstructured":"Navia JL, Kapadia S, Elgharably H, Harb SC, Krishnaswamy A, Unai S, et al. First-in-human implantations of the navigate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ Cardiovasc Interv. 2017;10.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005840"},{"key":"2051_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jcmg.2018.08.034","volume":"12","author":"RT Hahn","year":"2019","unstructured":"Hahn RT, George I, Kodali SK, Nazif T, Khalique OK, Akkoc D, et al. Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging. 2019;12:416\u201329.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2051_CR46","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jcin.2020.03.026","volume":"13","author":"FL Lu","year":"2020","unstructured":"Lu FL, Ma Y, An Z, Cai CL, Li BL, Song ZG, et al. First-in-man experience of transcatheter tricuspid valve replacement with lux-valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv. 2020;13:1614\u20136.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR47","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.jcin.2022.06.023","volume":"15","author":"M Barreiro-Perez","year":"2022","unstructured":"Barreiro-Perez M, Estevez-Loureiro R, Baz JA, Pi\u00f1\u00f3n MA, Maisano F, Puga L, et al. Cardiovalve transfemoral tricuspid valve replacement assisted with CT-fluoroscopy fusion imaging. JACC Cardiovasc Interv. 2022;15:e197\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR48","doi-asserted-by":"publisher","first-page":"e1088","DOI":"10.4244\/EIJ-D-22-00517","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Lu F, Li W, Chen S, Li M, Zhang X, et al. A first-in-human study of transjugular transcatheter tricuspid valve replacement with the LuX-Valve Plus system. EuroIntervention. 2023;18:e1088\u20139.","journal-title":"EuroIntervention"},{"key":"2051_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaccas.2022.02.008","volume":"4","author":"D Hagemeyer","year":"2022","unstructured":"Hagemeyer D, Merdad A, Ong G, Fam NP. Acute afterload mismatch after transcatheter tricuspid valve repair. JACC Case reports. 2022;4:519\u201322.","journal-title":"JACC Case reports"},{"key":"2051_CR50","unstructured":"\u2022\u2022 Kodali S, on behalf of the TRISCEND II investigators. TRISCEND II trial: a randomized trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. Presented at: TCT 2023. October 26, 2023. San Francisco, CA.\u00a0This presentation includes initial data from the first pivotal randomized clinical trial evaluating orthotopic transcatheter tricuspid valve replacement."},{"key":"2051_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","volume":"77","author":"P Lurz","year":"2021","unstructured":"Lurz P, Stephan von Bardeleben R, Weber M, Sitges M, Sorajja P, Hausleiter J, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77:229\u201339.","journal-title":"J Am Coll Cardiol."},{"key":"2051_CR52","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig G, Weber M, Lurz P, von Bardeleben RS, Sitges M, Sorajja P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019;394:2002\u201311.","journal-title":"Lancet"},{"key":"2051_CR53","doi-asserted-by":"crossref","unstructured":"Arnold SV, Goates S, Sorajja P, Adams DH, Stephan von Bardeleben R, Kapadia SR, et al. Health status after transcatheter tricuspid-valve repair in patients with severe tricuspid regurgitation: results from the TRILUMINATE pivotal trial. J Am Coll Cardiol. 2023.","DOI":"10.1016\/j.jacc.2023.10.008"},{"key":"2051_CR54","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.jcin.2019.09.046","volume":"12","author":"NP Fam","year":"2019","unstructured":"Fam NP, Braun D, von Bardeleben RS, Nabauer M, Ruf T, Connelly KA, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2019;12:2488\u201395.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2020.11.047","volume":"77","author":"S Kodali","year":"2021","unstructured":"Kodali S, Hahn RT, Eleid MF, Kipperman R, Smith R, Lim DS, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021;77:345\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR56","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.jacc.2023.02.049","volume":"81","author":"SK Kodali","year":"2023","unstructured":"Kodali SK, Hahn RT, Davidson CJ, Narang A, Greenbaum A, Gleason P, et al. 1-year outcomes of transcatheter tricuspid valve repair. J Am Coll Cardiol. 2023;81:1766\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR57","doi-asserted-by":"publisher","first-page":"e010770","DOI":"10.1161\/CIRCINTERVENTIONS.121.010770","volume":"14","author":"M Aurich","year":"2021","unstructured":"Aurich M, Volz MJ, Mereles D, Geis NA, Frey N, Konstandin MH, et al. Initial experience with the PASCAL ace implant system for treatment of severe tricuspid regurgitation. Circ Cardiovasc Interv. 2021;14:e010770.","journal-title":"Circ Cardiovasc Interv"},{"key":"2051_CR58","volume-title":"PASCAL (CLASP IITR update)","author":"DD Wang","year":"2023","unstructured":"Wang DD. PASCAL (CLASP IITR update). Phoenix, Arizona: TVT 2023; 2023."},{"key":"2051_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmg.2018.09.027","volume":"12","author":"EA Prihadi","year":"2019","unstructured":"Prihadi EA, Delgado V, Leon MB, Enriquez-Sarano M, Topilsky Y, Bax JJ. Morphologic types of tricuspid regurgitation: characteristics and prognostic implications. JACC Cardiovasc Imag. 2019;12:491\u20139.","journal-title":"JACC Cardiovasc Imag"},{"key":"2051_CR60","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.jvca.2021.06.025","volume":"36","author":"XX Zhang","year":"2022","unstructured":"Zhang XX, Wei M, Xiang R, Lu YM, Zhang L, Li YD, et al. Incidence, risk factors, and prognosis of tricuspid regurgitation after cardiac implantable electronic device implantation: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2022;36:1741\u201355.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2051_CR61","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1093\/ehjci\/jead273","volume":"25","author":"I Stankovic","year":"2023","unstructured":"Stankovic I, Voigt J-U, Burri H, Muraru D, Sade LE, Haugaa KH, et al. Imaging in patients with cardiovascular implantable electronic devices: part 2\u2014imaging after device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J Cardiovasc Imag. 2023;25:e33\u201354.","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"2051_CR62","doi-asserted-by":"crossref","unstructured":"Sorajja P, Sato H, Abdelhadi R, Zakaib J, Enriquez-Sarano M, Bapat V, et al. The impact and outcomes of RV lead extraction in CIED-related tricuspid regurgitation. JACC Cardiovasc Interv. 2023.","DOI":"10.1016\/j.jcin.2023.04.018"},{"key":"2051_CR63","doi-asserted-by":"crossref","unstructured":"Blusztein DI, Hahn RT. New therapeutic approach for tricuspid regurgitation: transcatheter tricuspid valve replacement or repair. Front Cardiovasc Med. 2023;10.","DOI":"10.3389\/fcvm.2023.1080101"},{"key":"2051_CR64","doi-asserted-by":"crossref","unstructured":"Sala A, Hahn RT, Kodali SK, Mack MJ, Maisano F. Tricuspid valve regurgitation: current understanding and novel treatment options. J Soc Cardiovas Angiogr Interv. 2023;101041.","DOI":"10.1016\/j.jscai.2023.101041"},{"key":"2051_CR65","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.jacc.2023.04.014","volume":"81","author":"L Stolz","year":"2023","unstructured":"Stolz L, Weckbach LT, Hahn RT, Chatfield AG, Fam NP, von Bardeleben RS, et al. 2-year outcomes following transcatheter tricuspid valve replacement using the EVOQUE system. J Am Coll Cardiol. 2023;81:2374\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcin.2022.09.035","volume":"16","author":"HD Danenberg","year":"2023","unstructured":"Danenberg HD, Topilsky Y, Planer D, Maor E, Guetta V, Sievert H, et al. Tricuspid valve repair by chordal grasping: mistral first-in-human trial results at 6 months. JACC Cardiovasc Interv. 2023;16:244\u20136.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR67","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.4244\/EIJ-D-22-01032","volume":"19","author":"K Piayda","year":"2023","unstructured":"Piayda K, Bertog S, Steffan J, Ilioska-Damkohler P, Beeri R, Sievert K, et al. One-year outcomes of transcatheter tricuspid valve repair with the Mistral device. EuroIntervention. 2023;19:e363\u20135.","journal-title":"EuroIntervention"},{"key":"2051_CR68","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jcin.2017.06.036","volume":"10","author":"G Perlman","year":"2017","unstructured":"Perlman G, Praz F, Puri R, Ofek H, Ye J, Philippon F, et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv. 2017;10:1994\u20132003.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR69","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jcin.2019.04.038","volume":"12","author":"L Asmarats","year":"2019","unstructured":"Asmarats L, Perlman G, Praz F, Hensey M, Chrissoheris MP, Philippon F, et al. Long-term outcomes of the FORMA transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation: insights from the first-in-human experience. JACC Cardiovasc Interv. 2019;12:1438\u201347.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR70","doi-asserted-by":"publisher","first-page":"B32","DOI":"10.1016\/j.jacc.2018.08.1166","volume":"72","author":"C Meduri","year":"2018","unstructured":"Meduri C, Hahn R, Davidson C, Lim S, Nazif T, Ricciardi M, et al. TCT-74 SCOUT study: Trialign results at 30 days from combined US and EU cohort for the treatment of functional TR. J Am Coll Cardiol. 2018;72:B32\u20133.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR71","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jacc.2017.01.054","volume":"69","author":"RT Hahn","year":"2017","unstructured":"Hahn RT, Meduri CU, Davidson CJ, Lim S, Nazif TM, Ricciardi MJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol. 2017;69:1795\u2013806.","journal-title":"J Am Coll Cardiol"},{"key":"2051_CR72","doi-asserted-by":"publisher","first-page":"131174","DOI":"10.1016\/j.ijcard.2023.131174","volume":"390","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jin Q, Pan W, Li W, Guo Y, Ma G, et al. First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation. Int J Cardiol. 2023;390:131174.","journal-title":"Int J Cardiol"},{"key":"2051_CR73","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.4244\/EIJ-D-20-01107","volume":"16","author":"G Nickenig","year":"2021","unstructured":"Nickenig G, Weber M, Sch\u00fcler R, Hausleiter J, Nabauer M, von Bardeleben RS, et al. Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention. 2021;16:e1264\u201371.","journal-title":"EuroIntervention"},{"key":"2051_CR74","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jcin.2022.07.006","volume":"15","author":"WA Gray","year":"2021","unstructured":"Gray WA, Abramson SV, Lim S, Fowler D, Smith RL, Grayburn PA, et al. Cardioband TREFSI. 1-year outcomes of Cardioband tricuspid valve reconstruction system early feasibility study. JACC Cardiovasc Interv. 2021;15:1921\u201332.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR75","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4244\/EIJ-D-19-00901","volume":"15","author":"H Dreger","year":"2020","unstructured":"Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, et al. Treatment of severe TRIcuspid regurgitation in patients with advanced heart failure with CAval vein implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial. EuroIntervention. 2020;15:1506\u201313.","journal-title":"EuroIntervention"},{"key":"2051_CR76","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jcin.2022.05.022","volume":"15","author":"R Estevez-Loureiro","year":"2022","unstructured":"Estevez-Loureiro R, Sanchez-Recalde A, Amat-Santos IJ, Cruz-Gonzalez I, Baz JA, Pascual I, et al. 6-month outcomes of the TricValve system in patients with tricuspid regurgitation: the TRICUS EURO study. JACC Cardiovasc Interv. 2022;15:1366\u201377.","journal-title":"JACC Cardiovasc Interv"},{"key":"2051_CR77","doi-asserted-by":"publisher","first-page":"e011302","DOI":"10.1161\/CIRCINTERVENTIONS.121.011302","volume":"15","author":"MG Wild","year":"2022","unstructured":"Wild MG, Lubos E, Cruz-Gonzalez I, Amat-Santos I, Ancona M, Andreas M, et al. Early clinical experience with the TRICENTO bicaval valved stent for treatment of symptomatic severe tricuspid regurgitation: a multicenter registry. Circ Cardiovasc Interv. 2022;15:e011302.","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02051-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:17:42Z","timestamp":1719299862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02051-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"20 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Madhavan reports institutional educational grant to Columbia University from Boston Scientific Corporation. Dr. Agarwal reports speaker fees from Abbott Structural, and consulting for Moray Medical, HVR Cardio, and ReNiva Inc. Dr. Hahn reports speaker fees from Abbott Structural, Baylis Medical, Boston Scientific Corporation, Edwards Lifesciences, Philips Healthcare, and Siemens Healthineers and is Chief Scientific Officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored trials, for which she receives no direct industry compensation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}